Soft printable robots may help care for the elderly with a gentle touch

Industrial and biomedical engineers at Purdue University have demonstrated a way to print devices in 3D such that they squeeze, move and otherwise feel like human hands. The team’s hope is to create soft robots that can help care for elderly patients with a human-like touch when nursing shortages become the norm.

Ramses Martinez, PhD, and co-authors published their work online April 8 in Advanced Functional Materials.

Building off recent advances in material science that are promising but likely too complex for commercialization, Martinez and colleagues came up with a novel process for designing architected soft machines (ASMs).

The process incorporates an algorithm that can quickly convert a computer-aided design (CAD) model of a robot into an ASM using any readily available 3D printer, according to Purdue’s newsroom.

Because the designer can use the CAD to plan how the joints of the soft robot will move, the result is ASMs that replicate muscle movements using miniature motors that pull nylon lines to, for example, close the soft robot’s fingers.  

“ASMs can perform complex motions such as gripping or crawling with ease, and this work constitutes a step forward toward the development of autonomous and lightweight soft robots,” Martinez said. “The capability of ASMs to change their body configuration and gait to adapt to a wide variety of environments has the potential to not only improve caregiving but also disaster-response robotics.”

Purdue’s newsroom notes that the population of people over 60 is expected to more than double by 2050, straining the healthcare system’s ability to tend to elderly patients who require 24-hour care.

Martinez added that existing caregiving robots are limited to nonphysical social interactions, as their hard edges and surfaces present safety concerns.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.